Hund, Hajo
Boodt, Nikki http://orcid.org/0000-0003-4020-7199
Arrarte Terreros, Nerea
Taha, Aladdin
Marquering, Henk A.
van Es, Adriaan C. G. M.
Bokkers, Reinoud P. H.
Lycklama à Nijeholt, Geert J.
Majoie, Charles B.L.M.
Dippel, Diederik W.J.
Lingsma, Hester F.
van Beusekom, Heleen M. M.
van der Lugt, Aad
,
Article History
Received: 2 December 2021
Revised: 14 March 2022
Accepted: 21 March 2022
First Online: 30 April 2022
Declarations
:
: Institutional Review Board approval was obtained.
: Written informed consent was waived by the Institutional Review Board.
: The authors of this manuscript declare relationships with the following companies: Erasmus Medical Center received compensation from Stryker, Siemens Healthineers, and GE Healthcare for activities of A.v.d.L. Dr. Dippel and Dr. Van der Lugt report grants from Dutch Heart Foundation, grants from Brain Foundation Netherlands, grants from Health Holland Top Sector Life Sciences & Health, grants from the Netherlands Organisation for Health Research and Development, and unrestricted grants from Stryker European Operations BV; from Penumbra Inc.; from Medtronic; from Thrombolytic Science, LLC; and from Cerenovus outside the submitted work, all paid to institution. H.A.M. is co-founder and shareholder of Nicolab, a company that focuses on the use of artificial intelligence for medical image analysis. C.B.L.M. is a recipient of grants from the CVON/Dutch Heart Foundation, Stryker, European Commission, TWIN Foundation, and Health Evaluation Netherlands and is shareholder of Nicolab.
: The scientific guarantor of this publication is prof. Aad van der Lugt, Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
: One of the authors has significant statistical expertise.
: • prospective• observational• multicenter study